On 2024-02-28, Atea Pharmaceuticals, Inc. (AVIR) announced earnings per share of $-0.47 for the fiscal quarter ending 2023-12-31, missing the average analyst estimate of $-0.44.
The next expected annoucement date for quarterly earnings is 2024-05-13, with an average estimated earnings per share of $-0.61 for the fiscal quarter ending 2024-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-02-28 | 2023-12-31 | $-0.44 | $-0.47 |
| 2023-11-08 | 2023-09-30 | $-0.46 | $-0.40 |
| 2023-08-08 | 2023-06-30 | $-0.47 | $-0.34 |
| 2023-05-08 | 2023-03-31 | $-0.51 | $-0.43 |
| 2023-02-28 | 2022-12-31 | $-0.45 | $-0.41 |
| 2022-11-07 | 2022-09-30 | $-0.44 | $-0.10 |
| 2022-08-08 | 2022-06-30 | $-0.52 | $-0.38 |
| 2022-05-10 | 2022-03-31 | $-0.58 | $-0.51 |
| 2022-02-28 | 2021-12-31 | $0.33 | $1.34 |
| 2021-11-11 | 2021-09-30 | $-0.05 | $-0.34 |
| 2021-08-12 | 2021-06-30 | $0.01 | $0.02 |
| 2021-05-13 | 2021-03-31 | $-0.06 | $0.34 |
| 2020-12-10 | 2020-09-30 | $-1.06 | $-1.74 |